#289 Keeping it Simple for Emergency Room Dyspepsia
Reading Tools for Practice Article can earn you MainPro+ CreditsJoin Now
Already a CFPCLearn Member? Log in
- 89 patients randomized to antacid (Gastrogel®), antacid + lidocaine solution 2%, or antacid + viscous lidocaine 2%.1 At 30 minutes:
- Mean pain score improvement: No statistical difference between groups (antacid 24, antacid + lidocaine solution 20, antacid + viscous lidocaine 15 points).
- Overall acceptability significantly (13-25 points) higher for antacid alone.
- 14% of patients ultimately had cardiac diagnosis.
- 113 patients randomized to antacid (Mylanta®), antacid + antispasmodic (Donnatal®), or antacid + antispasmodic + lidocaine. 2 At 30 minutes:
- Mean pain score improvement: No statistical difference between groups: (antacid 25; antacid + antispasmodic 23; antacid, antispasmodic + lidocaine 24 points).
- 73 patients randomized to antacid (Mylanta®) or antacid + viscous lidocaine 2%.3 At 30 minutes:
- Mean pain score improvement: Antacid + lidocaine was greater than antacid alone (41 versus 9 points, statistically different).
- Patient-reported “acceptable” pain relief: 69% for antacid + lidocaine versus 35% for antacid alone; number needed to treat=3.
- Limitation: Clinicians not blinded.
- Dyspepsia affects up to 16% of healthy individuals, with abdominal pain accounting for up to 9% of emergency room visits. 4,5
- Women with an acute myocardial infarction often experience prodromal symptoms and chest pain is less predictive of coronary artery disease:
- Up to 45% of women have gastrointestinal symptoms as the presenting symptom compared to 34% in men. 6
- Response to antacids should not be used for differentiating gastrointestinal or cardiac origin of pain. 7